Fujian Cosunter Pharmaceutical Co., Ltd. reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 279.69 million compared to CNY 297.47 million a year ago. Revenue was CNY 279.69 million compared to CNY 297.47 million a year ago.

Net loss was CNY 195.83 million compared to CNY 71.49 million a year ago. Basic loss per share from continuing operations was CNY 1.2295 compared to CNY 0.4495 a year ago. Diluted loss per share from continuing operations was CNY 1.2295 compared to CNY 0.4495 a year ago.